Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 16/20 | 0.55 |
| ▸ | PDE4B | Q07343 | 12/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 12/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 12/20 | 0.51 |
| ▸ | FPR2 | P25090 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7439719 | 0.95 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL5823060 | 0.79 | PDE4A (0.77) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL7434251 | 0.79 | PDE4A (0.54) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL6817584 | 0.78 | PDE4A (0.62) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL7436089 | 0.78 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL7364691 | 0.75 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL6919617 | 0.75 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL7444972 | 0.75 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL8766261 | 0.75 | PDE4A (0.59) | PDE4APDE4BPDE4CPDE4DFPR2 | |
| SCHEMBL9323987 | 0.74 | PDE4A (0.58) | PDE4APDE4BPDE4CPDE4DFPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5541219-A | 1-Alkoxy-2-(alkoxy- or cycloalkoxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-) benzenes as inhibitors of cyclic AMP phosphodiesterase and tumor necrosis factor | RHONE-POULENC RORER LIMITED (GB) | 1996-07-30 | — | — | US | claimed |
| EP-0629197-A1 | 1-ALKOXY-(2-ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR. | RHONE POULENC RORER LTD (GB) | 1994-12-21 | — | — | EP | claimed |
| WO-1993018024-A1 | 1-ALKOXY-2-(ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR | RHONE-POULENC RORER LIMITED (GB) | 1993-09-16 | — | — | WO | claimed |
| EP-0629197-B1 | 1-ALKOXY-(2-ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR | RHONE POULENC RORER LTD (GB) | 1997-08-20 | — | — | EP | disclosed |
| US-5541219-A | 1-Alkoxy-2-(alkoxy- or cycloalkoxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-) benzenes as inhibitors of cyclic AMP phosphodiesterase and tumor necrosis factor | RHONE-POULENC RORER LIMITED (GB) | 1996-07-30 | — | — | US | disclosed |
| EP-0629197-A1 | 1-ALKOXY-(2-ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR. | RHONE POULENC RORER LTD (GB) | 1994-12-21 | — | — | EP | disclosed |
| WO-1993018024-A1 | 1-ALKOXY-2-(ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR | RHONE-POULENC RORER LIMITED (GB) | 1993-09-16 | — | — | WO | disclosed |